Original document(49 pages) Authorized document(44 pages) 中文版
    Benzazecinediones of the formula I wherein R1 and R2 are independently hydrogen or chlorine, R3 is hydrogen, fluorine, chlorine, bromine or methoxy, R4 is hydrogen, chlorine or methoxy and R5 is hydrogen, acetyl, propionyl, benzoyl, chlorobenzoyl, methoxybenzoyl or phenylacetyl, with the proviso that 2 or 3 of the groups R1 to R4 are hydrogen. as well as many of the corresponding benzo[f]quinolines from which these benzazecinediones can be prepared by oxidation are suitable for the control or prevention of cerebral insufficiency or for the improvement of cognitive functions in mammals. They can be produced according to various processes and can be prepared into pharmaceutical compositions.
Application Number
申请号
87100312 Application Date
申请日
1987.01.22
Title 名称 Benzazecin derivative
Publication Number
公开号
1013148 Publication Date
公开日
1987.09.09
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/395;C07D221/10;C07D225/06
Applicant(s) Name
申请人
F. Hoffmann-La Roche & Co.
Address 地址
Inventor(s) Name 发明人 Rene Imhof;Werner Aschwanden
Attorney & Agent 代理人 MA CHONGDE
More information 更  多  信  息


 Related patents information
Hydrocinnamic acid derivatives
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.